The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer
Abstract
Breast cancer (BC) is the most frequently occurring malignancy in women worldwide. Despite the substantial advancement in understanding the molecular mechanisms and management of BC, it remains the leading cause of cancer death in women. One of the main reasons for this obstacle is that we have not been able to find the Achilles heel for the BC as a highly heterogeneous disease. Accumulating evidence has revealed that noncoding RNAs (ncRNAs), play key roles in the development of BC; however, the involving of complex regulatory interactions between the different varieties of ncRNAs in the development of this cancer has been poorly understood. In the recent years, the newly discovered mechanism in the RNA world is “competing endogenous RNA (ceRNA)” which proposes regulatory dialogues between different RNAs, including long ncRNAs (lncRNAs), microRNAs (miRNAs), transcribed pseudogenes, and circular RNAs (circRNAs). In the latest BC research, various studies have revealed that dysregulation of several ceRNA networks (ceRNETs) between these ncRNAs has fundamental roles in establishing the hallmarks of BC development. And it is thought that such a discovery could open a new window for a better understanding of the hidden aspects of breast tumors. Besides, it probably can provide new biomarkers and potential efficient therapeutic targets for BC. This review will discuss the existing body of knowledge regarding the key functions of ceRNETs and then highlights the emerging roles of some recently discovered ceRNETs in several hallmarks of BC. Moreover, we propose for the first time the “ceRnome” as a new term in the present article for RNA research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.
Tian, H., Hou, L., Xiong, Y., Huang, J.-X., Zhang, W., Pan, Y., & Song, X. (2016) · PubMed · Cited by 40
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Molecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 1×
“TRAF6 and EGFR are activating mediators of the nuclear transcription factor‐κB (NF‐κB) signaling pathway (T. Zheng, Chou, et al., 2015), which plays a key role in proliferation, survival, and metastasis of cancer cells (Karin, 2006).”
BackgroundPrinciples of MicroRNA–Target Recognition
Brennecke, J., Stark, A., Russell, R. B., & Cohen, S. M. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030085 · Cited by 2,378
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010) · Nature · doi:10.1038/nature09144 · Cited by 2,323
Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
Li, Y., Zheng, Q., Bao, C., Li, S., Guo, W., Zhao, J., Chen, D., Gu, J., He, X., & Huang, S. (2015) · Cell Research · doi:10.1038/cr.2015.82 · Cited by 2,204
Endogenous microRNA sponges: evidence and controversy
Thomson, D. W., & Dinger, M. E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.20 · Cited by 2,185
The RNA Binding Protein Quaking Regulates Formation of circRNAs
Conn, S. J., Pillman, K. A., Toubia, J., Conn, V. M., Salmanidis, M., Phillips, C. A., Roslan, S., Schreiber, A. W., Gregory, P. A., & Goodall, G. J. (2015) · Cell · doi:10.1016/j.cell.2015.02.014 · Cited by 2,178
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Gutschner, T., Hämmerle, M., Eißmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Groß, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2850 · Cited by 1,415
Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
Martinou, J.-C., & Youle, R. J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.017 · Cited by 1,368
Circular RNAs in cancer: opportunities and challenges in the field
Kristensen, L. S., Hansen, T. B., Venø, M. T., & Kjems, J. (2018) · Oncogene · doi:10.1038/onc.2017.361 · Cited by 1,326
ceRNA in cancer: possible functions and clinical implications
Qi, X., Zhang, D.-H., Wu, N., Xiao, J.-H., Wang, X., & Ma, W. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103334 · Cited by 1,271
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes
Watanabe, T., Totoki, Y., Toyoda, A., Kaneda, M., Kuramochi-Miyagawa, S., Obata, Y., Chiba, H., Kohara, Y., Kono, T., Nakano, T., et al. (2008) · Nature · doi:10.1038/nature06908 · Cited by 1,116
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.029 · Cited by 1,019
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
Early Breast Cancer Trialists' Collaborative Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192601 · Cited by 933
Circular RNA and its mechanisms in disease: From the bench to the clinic
Han, B., Chao, J., & Yao, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.010 · Cited by 788
Wang, Y., Xu, Z., Jiang, J., Xu, C., Kang, J., Xiao, L., Wu, M., Xiong, J., Guo, X., & Liu, H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.002 · Cited by 781
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
Kulcheski, F. R., Christoff, A. P., & Margis, R. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.09.011 · Cited by 740
Hangauer, M. J., Vaughn, I. W., & McManus, M. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003569 · Cited by 738
Suzuki, H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl151 · Cited by 695
The Landscape of MicroRNA, Piwi-Interacting RNA, and Circular RNA in Human Saliva
Bahn, J. H., Zhang, Q., Li, F., Chan, T.-M., Lin, X., Kim, Y., Wong, D. T. W., & Xiao, X. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.230433 · Cited by 657
Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction
Ishii, N., Ozaki, K., Sato, H., Mizuno, H., Saito, S., Takahashi, A., Miyamoto, Y., Ikegawa, S., Kamatani, N., Hori, M., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0070-9 · Cited by 652
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., & Galun, E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000845 · Cited by 650
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., & Benz, C. C. (2008) · Oncogene · doi:10.1038/onc.2008.171 · Cited by 622
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Paplomata, E., & O’Regan, R. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014530023 · Cited by 593
miR-19 is a key oncogenic component of mir-17-92
Olive, V., Bennett, M. J., Walker, J. C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q.-J., Lowe, S. W., Hannon, G. J., & He, L. (2009) · Genes & Development · doi:10.1101/gad.1861409 · Cited by 588
Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., & Qiu, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.033 · Cited by 549
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7376 · Cited by 501
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
Stingl, J., & Caldas, C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2212 · Cited by 470
Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K., & Akimitsu, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.008 · Cited by 424
Exon Skipping Is Correlated with Exon Circularization
Kelly, S., Greenman, C., Cook, P. R., & Papantonis, A. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.018 · Cited by 373
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
He, R., Liu, P., Xie, X., Zhou, Y., Liao, Q., Xiong, W., Li, X., Li, G., Zeng, Z., & Tang, H. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0614-1 · Cited by 347
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Farazi, T. A., Horlings, H. M., ten Hoeve, J. J., Mihailovic, A., Halfwerk, H., Morozov, P., Brown, M., Hafner, M., Reyal, F., van Kouwenhove, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0608 · Cited by 346
The GENCODE pseudogene resource
Pei, B., Sisu, C., Frankish, A., Howald, C., Habegger, L., Mu, X. J., Harte, R., Balasubramanian, S., Tanzer, A., Diekhans, M., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r51 · Cited by 342
Liang, H., Zhang, X.-Z., Liu, B., Jia, G., & Li, W. (2017) · PubMed Central · Cited by 329
Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 325
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321
Li, L., Yuan, L., Luo, J., Gao, J., Guo, J., & Xie, X. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0186-5 · Cited by 314
Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers
Kalyana-Sundaram, S., Kumar-Sinha, C., Shankar, S., Robinson, D. R., Wu, Y.-M., Cao, X., Asangani, I. A., Kothari, V., Prensner, J. R., Lonigro, R. J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.041 · Cited by 301
A pseudogene structure in 5S DNA of Xenopus laevis
Jacq, C., Miller, J. R., & Brownlee, G. G. (1977) · Cell · doi:10.1016/0092-8674(77)90189-1 · Cited by 301
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Eades, G., Wolfson, B., Zhang, Y., Li, Q., Yao, Y., & Zhou, Q. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0251 · Cited by 271
Function and clinical significance of circRNAs in solid tumors
Geng, Y., Jiang, J., & Wu, C. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0643-z · Cited by 263
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Dubrovska, A., Cojoc, M., Peitzsch, Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 254
Development of subtype-selective oestrogen receptor-based therapeutics
Nilsson, S., Koehler, K. F., & Gustafsson, J.-Å. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3551 · Cited by 249
Insulin‐like growth factor ligands, receptors, and binding proteins in cancer
Foulstone, E., Prince, S., Zaccheo, O., Burns, J., Harper, J., Jacobs, C., Church, D., & Hassan, A. (2005) · The Journal of Pathology · doi:10.1002/path.1712 · Cited by 245
H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Peng, F., Li, T.-T., Wang, K.-L., Xiao, G.-Q., Wang, J.-H., Zhao, H.-D., Kang, Z.-J., Fan, W.-J., Zhu, L.-L., Li, M., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.438 · Cited by 244
Pseudogenes regulate parental gene expression via ce RNA network
An, Y., Furber, K. L., & Ji, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12952 · Cited by 227
The role of CD44 in epithelial–mesenchymal transition and cancer development
Wu, K., Xu, H., Tian, Y., Yuan, X., Wu, H., Liu, Q., & Pestell, R. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s95470 · Cited by 223
Zhou, W., Ye, X.-L., Xu, J., Cao, M.-G., Fang, Z.-Y., Li, L.-Y., Guan, G.-H., Liu, Q., Qian, Y.-H., & Xie, D. (2017) · Science Signaling · doi:10.1126/scisignal.aak9557 · Cited by 222
Craig, D. W., O'Shaughnessy, J. A., Kiefer, J. A., Aldrich, J., Sinari, S., Moses, T. M., Wong, S., Dinh, J., Christoforides, A., Blum, J. L., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0781 · Cited by 220 · cited 9×
“, 2014), CDH5 (Craig et al., 2013), HOXD1 (Jeschke et al.”
BackgroundInfluentialMiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
Cho, W. C., Chow, A. S., & Au, J. S. (2011) · RNA Biology · doi:10.4161/rna.8.1.14259 · Cited by 220
Li, X., Xie, W., Xie, C., Huang, C., Zhu, J., Liang, Z., Deng, F., Zhu, M., Zhu, W., Wu, R., et al. (2014) · Phytotherapy Research · doi:10.1002/ptr.5167 · Cited by 206
Olsson, E., Honeth, G., Bendahl, P.-O., Saal, L. H., Gruvberger-Saal, S., Ringnér, M., Vallon-Christersson, J., Jönsson, G., Holm, K., Lövgren, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-418 · Cited by 204
MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells
Tang, F., Zhang, R., He, Y., Zou, M., Guo, L., & Xi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035435 · Cited by 203
LATS tumor suppressor: A new governor of cellular homeostasis
Visser, S., & Yang, X. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13386 · Cited by 202
Fang, W. B., Jokar, I., Zou, A., Lambert, D., Dendukuri, P., & Cheng, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365999 · Cited by 197
Yu, G., Yao, W., Gumireddy, K., Li, A., Wang, J., Xiao, W., Chen, K., Xiao, H., Li, H., Tang, K., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0245 · Cited by 197
Christensen, L. L., True, K., Hamilton, M. P., Nielsen, M. M., Damas, N. D., Damgaard, C. K., Ongen, H., Dermitzakis, E., Bramsen, J. B., Pedersen, J. S., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.06.003 · Cited by 194
Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C., & Yang, B. B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1003 · Cited by 193
Molnár, Á., Theodoras, A. M., Zon, L. I., & Kyriakis, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13229 · Cited by 190
Wu, X.-S., Wang, X.-A., Wu, W.-G., Hu, Y.-P., Li, M.-L., Ding, Q., Weng, H., Shu, Y.-J., Liu, T.-Y., Jiang, L., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28584 · Cited by 187
Chou, J., Wang, B., Zheng, T., Li, X., Zheng, L., Hu, J., Zhang, Y., Xing, Y., & Xi, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.102 · Cited by 184
Zhang, J., Guo, H., Zhang, H., Wang, H., Qian, G., Fan, X., Hoffman, A. R., Hu, J., & Ge, S. (2011) · Cancer · doi:10.1002/cncr.25522 · Cited by 181
Yoder, B. J., Tso, E., Skacel, M., Pettay, J., Tarr, S., Budd, T., Tubbs, R. R., Adams, J. C., & Hicks, D. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.186.11.1 · Cited by 181
Lü, L., Sun, J., Shi, P., Kong, W., Xu, K., He, B., Zhang, S., & Wang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17307 · Cited by 181
Recapitulation of Short RNA-Directed Translational Gene Silencing In Vitro
Wang, B., Love, T. M., Call, M. E., Doench, J. G., & Novina, C. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.034 · Cited by 179
Role of miR-10b in breast cancer metastasis
Ma, L. (2010) · Breast Cancer Research · doi:10.1186/bcr2720 · Cited by 178
Han, L., Yuan, Y., Zheng, S., Yang, Y., Li, J., Edgerton, M. E., Diao, L., Xu, Y., Verhaak, R. G. W., & Liang, H. (2014) · Nature Communications · doi:10.1038/ncomms4963 · Cited by 178
SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5
Cai, C., Huo, Q., Wang, X., Chen, B., & Yang, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.094 · Cited by 166
Li, Q.-Q., Chen, Z.-Q., Cao, X.-X., Xu, J.-D., Xu, J.-W., Chen, Y.-Y., Wang, W.-J., Chen, Q., Tang, F., Liu, X.-P., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.103 · Cited by 165
Screening Circular RNA Related to Chemotherapeutic Resistance in Breast Cancer
Gao, D., Zhang, X., Liu, B., Meng, D., Fang, K., Guo, Z., & Li, L. (2017) · Epigenomics · doi:10.2217/epi-2017-0055 · Cited by 160
Zeng, Z., Lin, H., Zhao, X., Liu, G., Wang, X., Xu, R., Chen, K., Li, J., & Song, L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3156 · Cited by 159
Seillier, M., Peuget, S., Gayet, O., Gauthier, C., N’guessan, P., Monte, M., Carrier, A., Iovanna, J., & Dusetti, N. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.30 · Cited by 155
Grossmann, A. H., Yoo, J. H., Clancy, J. W., Sorensen, L. K., Sedgwick, A., Tong, Z., Ostanin, K., Rogers, A., Grossmann, K. F., Tripp, S. R., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003398 · Cited by 152
Wang, H., Xiao, Y., Wu, L., & Ma, D. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4265 · Cited by 151
Miao, Y., Zheng, W., Li, N., Su, Z., Zhao, L., Zhou, H., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep41942 · Cited by 150
Luan, T., Zhang, X., Wang, S., Song, Y., Zhou, S., Lin, J., An, W., Yuan, W., Yang, Y., Cai, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19190 · Cited by 148
Soikkeli, J., Podlasz, P., Yin, M., Nummela, P., Jahkola, T., Virolainen, S., Krogerus, L. A., Heikkilä, P., von Smitten, K., Saksela, O., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090748 · Cited by 144
The Notch Pathway in Breast Cancer Progression
Kontomanolis, E. N., Kalagasidou, S., Pouliliou, S., Anthoulaki, X., Georgiou, N., Papamanolis, V., & Fasoulakis, Z. N. (2018) · The Scientific World JOURNAL · doi:10.1155/2018/2415489 · Cited by 142
Kong, Q., & Qiu, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.013 · Cited by 139
Gwak, J. M., Kim, H. J., Kim, E. J., Chung, Y. R., Yun, S., Seo, A. N., Lee, H. J., & Park, S. Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3069-5 · Cited by 136
Lee, E. Y., Chung, C. H., Khoury, C. C., Yeo, T. K., Pyagay, P. E., Wang, A., & Chen, S. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90642.2008 · Cited by 135
Siragam, V., Rutnam, Z. J., Yang, W., Fang, L., Luo, L., Yang, X., Li, M., Deng, Z., Qian, J., Peng, C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.717 · Cited by 134
Zheng, L., Li, X., Gu, Y., Lv, X., & Xi, T. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3298-2 · Cited by 134
The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
Xiao, X., Huang, X., Ye, F., Chen, B., Song, C., Wen, J., Zhang, Z., Zheng, G., Tang, H., & Xie, X. (2016) · Scientific Reports · doi:10.1038/srep21735 · Cited by 134
Shi, Y., Luo, X., Li, P., Tan, J., Wang, X., Xiang, T., & Ren, G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.014 · Cited by 131
Zhang, R., Guo, Y., Ma, Z., Ma, G., Xue, Q., Li, F., & Liu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15317 · Cited by 130
Zheng, L., Xiang, C., Li, X., Guo, Q., Gao, L., Ni, H., Xia, Y., & Xi, T. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0613-5 · Cited by 130
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
Sun, Y., Mao, X., Fan, C., Liu, C., Guo, A., Guan, S., Jin, Q., Li, B., Yao, F., & Jin, F. (2014) · Tumor Biology · doi:10.1007/s13277-014-1816-1 · Cited by 129
Li, Z., Li, Y., Li, Y., Ren, K., Li, X., Han, X., & Wang, J. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21933 · Cited by 129
IGF2 signaling and regulation in cancer
Brouwer‐Visser, J., & Huang, G. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.01.002 · Cited by 122
NEAT1 contributes to breast cancer progression through modulating miR‐448 and ZEB1
Jiang, X., Zhou, Y., Sun, A., & Xue, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26470 · Cited by 121
Nakagawara (2009) · International Journal of Oncology · doi:10.3892/ijo_00000219 · Cited by 118
Jiang, F., Liu, T., He, Y., Qin, Y., Chen, X., Wang, H., & Wan, X. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-425 · Cited by 117
Shen, Y., Dong, L., Zhou, R., Yao, J., Song, Y., Yang, H., Jiang, Q. L., & Yan, B. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12755 · Cited by 116
Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma
Li, G., Zhang, H., Wan, X., Yang, X., Zhu, C., Wang, A., He, L., Miao, R., Chen, S., & Zhao, H. (2014) · BioMed Research International · doi:10.1155/2014/780521 · Cited by 115
Liu, K., Hou, Y., Liu, Y., & Zheng, J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0353-9 · Cited by 113
The Role of Epigenetics and Long Noncoding RNA MIAT in Neuroendocrine Prostate Cancer
Crea, F., Venalainen, E., Ci, X., Cheng, H., Pikor, L. A., Parolia, A., Xue, H., Saidy, N. R. N., Lin, D., Lam, W. L., et al. (2016) · Epigenomics · doi:10.2217/epi.16.6 · Cited by 111
Yang, J., Li, T., Gao, C., Lv, X., Liu, K., Song, H., Xing, Y., & Xi, T. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.07.003 · Cited by 109
Long non-coding RNAs in stem cells and cancer
Eades, G. L., Zhang, Y., Li, Q., Xia, J., Yao, Y., & Zhou, Q. Y. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.134 · Cited by 109
Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis
Shahbazi, J., Lock, R. B., & Liu, T. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00080 · Cited by 104
Cui, J., Yang, Y., Li, H., Leng, Y.-J., Qian, K., Huang, Q., Zhang, C., Zhao, L., Chen, J., Sun, T., et al. (2014) · Oncogene · doi:10.1038/onc.2014.430 · Cited by 103
Wu, Z., Wang, C.-Q., Xiang, R., Liu, X., Ye, S., Yang, X.-Q., Zhang, G.-H., Xu, X.-C., Zhu, T., & Wu, Q. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-51 · Cited by 103
The Non-coding 3′UTR of CD44 Induces Metastasis by Regulating Extracellular Matrix Functions
Jeyapalan, Z., & Yang, B. B. (2012) · Journal of Cell Science · doi:10.1242/jcs.100818 · Cited by 103
Hu, B., Shi, B., Jarzynka, M. J., Yiin, J., D’Souza‐Schorey, C., & Cheng, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2110 · Cited by 100
Li, L., Xie, X., Luo, J., Liu, M., Xi, S., Guo, J., Kong, Y., Wu, M., Gao, J., Zeming, X., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.201 · Cited by 98
Thomsen, K. G., Lyng, M., Lænkholm, A., Søkilde, R., Nielsen, B. S., Litman, T., & Ditzel, H. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1969-9 · Cited by 98
Zhu, Y., Yu, M., Li, Z., Kong, C., Bi, J., Li, J., Gao, Z., & Li, Z. (2010) · Urology · doi:10.1016/j.urology.2010.09.022 · Cited by 97
microRNAs and ceRNAs: RNA networks in pathogenesis of cancer.
Su, X., Xing, J., Wang, Z., Chen, L., Cui, M., & Jiang, B. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2013.03.08 · Cited by 94
Zang, W., Wang, T., Wang, Y., Chen, X., Du, Y., Sun, Q., Li, M., Dong, Z., & Zhao, G. (2016) · Oncotarget · doi:10.18632/oncotarget.6963 · Cited by 91
DASHR: database of small human noncoding RNAs
Leung, Y. Y., Kuksa, P. P., Amlie‐Wolf, A., Valladares, O., Ungar, L., Kannan, S., Gregory, B. D., & Wang, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1188 · Cited by 90
Rajabi, H. N., Tagde, A., Alam, M., Bouillez, A., Pitroda, S. P., Suzuki, Y., & Kufe, D. W. (2016) · Oncogene · doi:10.1038/onc.2016.180 · Cited by 88
Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias
Sattari, A., Siddiqui, H., Moshiri, F., Ngankeu, A., Nakamura, T., Kipps, T. J., & Croce, C. M. (2016) · Oncotarget · doi:10.18632/oncotarget.11099 · Cited by 88
Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Yu, W., Chai, H., Li, Y., Zhao, H., Xie, X., Zheng, H., Wang, C., Wang, X., Yang, G., Cai, X., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.019 · Cited by 86
Li, Q., & Mattingly, R. R. (2008) · Neoplasia · doi:10.1593/neo.08968 · Cited by 84
HMGA1pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
Esposito, F., Martino, M. D., Petti, M. G., Forzati, F., Tornincasa, M., Federico, A., Arra, C., Pierantoni, G. M., & Fusco, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2202 · Cited by 81
Chen, S.-X., Yin, J.-F., Lin, B., Su, H., Zheng, Z., Xie, C., & Fei, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-4404-0 · Cited by 80
TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition
Yao, J., Xu, F., Zhang, D., Yi, W., Chen, X., Chen, G., & Zhou, E. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26231 · Cited by 79
STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer
Li, X., Zheng, L., Zhang, F., Hu, J., Chou, J., Liu, Y., Xing, Y., & Xi, T. (2016) · Oncotarget · doi:10.18632/oncotarget.8099 · Cited by 78
Li, R., Gao, J., Guo, L.-H., Huang, G.-Q., & Luo, W.-H. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.29 · Cited by 78
Kumaraswamy, E., Wendt, K. L., Augustine, L. A., Stecklein, S. R., Sibala, E. C., Li, D., Gunewardena, S., & Jensen, R. A. (2014) · Oncogene · doi:10.1038/onc.2014.363 · Cited by 77
TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression
Seux, M., Peuget, S., Montero, M.-P., Siret, C., Rigot, V., Clerc, P., Gigoux, V., Pellegrino, E., Pouyet, L., N’guessan, P., et al. (2011) · Oncogene · doi:10.1038/onc.2011.25 · Cited by 76
Current Status of Long Non-Coding RNAs in Human Breast Cancer
Cerk, S., Schwarzenbacher, D., Adiprasito, J. B., Stotz, M., Hutterer, G. C., Gerger, A., Ling, H. Y., Călin, G. A., & Pichler, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091485 · Cited by 76
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
Letelier, P. J., García, P., Leal, P., Álvarez, H., Ili, C., López, J., Castillo, J., Brebi, P., & Roa, J. C. (2014) · PubMed Central · Cited by 74
Chappell, J., Sun, Y., Singh, A. M., & Dalton, S. (2013) · Genes & Development · doi:10.1101/gad.211300.112 · Cited by 72
Hippo pathway and breast cancer stem cells
Maugeri‐Saccà, M., & Maria, R. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.12.004 · Cited by 72
SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153
Ma, Y., Xue, Y., Liu, X., Qu, C., Cai, H., Wang, P., Li, Z., Li, Z., & Liu, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5985 · Cited by 71
Mataki, H., Enokida, H., Chiyomaru, T., Mizuno, K., Matsushita, R., Goto, Y., Nishikawa, R., Higashimoto, I., Samukawa, T., Nakagawa, M., et al. (2014) · Journal of Human Genetics · doi:10.1038/jhg.2014.111 · Cited by 70
Zheng, L., Li, X., Xia, M., Chou, J., Hu, J., Zhang, F., Zhang, Z., Xing, Y., Liu, Y., & Xi, T. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.012 · Cited by 66
Jeschke, J., Neste, L. V., Glöckner, S. C., Dhir, M., Calmon, M. F., Deregowski, V., Criekinge, W. V., Vlassenbroeck, I., Koch, A., Chan, T. A.-T., et al. (2012) · Epigenetics · doi:10.4161/epi.20445 · Cited by 65
Jung, C., Hansen, M. A., Makunin, I. V., Korbie, D. J., & Mattick, J. S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-77 · Cited by 59
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity
Ablett, M. P., O’Brien, C., Sims, A. H., Farnie, G., & Clarke, R. B. (2013) · Oncotarget · doi:10.18632/oncotarget.1169 · Cited by 59
Zhang, H., Zheng, F., Yang, W., & Lu, J. (2017) · Gene · doi:10.1016/j.gene.2017.08.009 · Cited by 59
Liu, R., Li, J., Lai, Y., Liao, Y., Liu, R.-M., & Qiu, W. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.016 · Cited by 57
Yao, J., Zhou, E., Wang, Y., Xu, F., Zhang, D., & Zhong, D. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2132 · Cited by 56
Li, Y., Jiang, B., Wu, X., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.146 · Cited by 56
MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer
Lu, G.-F., Sun, Y., An, S., Xin, S., Ren, X., Zhang, D., Wu, P., Liao, W., Ding, Y., & Liang, L. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.06.014 · Cited by 55
Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor
Beltrán, A. S., Russo, A., Lara, H., Fan, C., Lizardi, P. M., & Blancafort, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024595 · Cited by 55
MiR-449a promotes breast cancer progression by targeting CRIP2
Shi, W., Bruce, J. P., Lee, M., Yue, S., Rowe, M. R., Pintilie, M., Kogo, R., Bissey, P.-A., Fyles, A., Yip, K. W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7753 · Cited by 55
MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.
Xu, H., Fei, D., Zong, S., & Fan, Z. (2016) · Europe PMC (PubMed Central) · Cited by 55
Hussain, A. R., Siraj, A. K., Ahmed, M., Bu, R., Pratheeshkumar, P., Alrashed, A. M., Qadri, Z., Ajarim, D. S., Al‐Dayel, F., Beg, S., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3627-4 · Cited by 55
Noncoding RNAs in breast cancer
Lo, P., Wolfson, B., Zhou, X., Duru, N., Gernapudi, R., & Zhou, Q. Y. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv055 · Cited by 54
MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer
Raychaudhuri, M., Bronger, H., Buchner, T., Kiechle, M. B., Weichert, W., & Avril, S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4132-9 · Cited by 53
HMGA1-pseudogene expression is induced in human pituitary tumors
Esposito, F., Martino, M. D., D’Angelo, D., et al. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1021520 · Cited by 52
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome
Umemura, S., Shirane, M., Takekoshi, S., Kusakabe, T., Itoh, J., Egashira, N., Tokuda, Y., Mori, K., & Osamura, Y. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604900 · Cited by 52
Non-coding RNA and pseudogenes in neurodegenerative diseases: “The (un)Usual Suspects”
Costa, V., Esposito, R., Aprile, M., & Ciccodicola, A. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00231 · Cited by 50
A novel computational method for inferring competing endogenous interactions
Sardina, D. S., Alaimo, S., Ferro, A., Pulvirenti, A., & Giugno, R. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw084 · Cited by 50
Li, Q., Yang, H., Wang, C., Shan, S., Wang, Y., Zhang, G., & Ren, T. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0233-x · Cited by 48
Identification of antisense RNA transcripts from a human DNA topoisomerase I pseudogene.
Zhou, B., Beidler, D. R., & Cheng, Y. (1992) · PubMed · Cited by 45
Martino, M. D., Forzati, F., Arra, C., Fusco, A., & Esposito, F. (2016) · Oncotarget · doi:10.18632/oncotarget.7427 · Cited by 45
Jensen, B. V., Johansen, J. S., Skovsgaard, T., Brandt, J., & Teisner, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10187 · Cited by 44
The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions
Rutnam, Z. J., & Yang, B. B. (2012) · Journal of Cell Science · doi:10.1242/jcs100818 · Cited by 44
TRAIL ‐induced miR‐146a expression suppresses CXCR 4‐mediated human breast cancer migration
Wang, D., Liu, D., Gao, J., Liu, M., Liu, S., Jiang, M., Liu, Y., & Zheng, D. (2013) · FEBS Journal · doi:10.1111/febs.12323 · Cited by 42
Hsiao, Y.-C., Yeh, M., Chen, Y., Liu, J., Tang, C., & Huang, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5700 · Cited by 42
HMGA1-pseudogene overexpression contributes to cancer progression
Esposito, F., Martino, M. D., Forzati, F., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.974440 · Cited by 41
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism
Martino, M. D., Forzati, F., Marfella, M., et al. (2016) · Scientific Reports · doi:10.1038/srep37622 · Cited by 40
The CCR2 3′UTR functions as a competing endogenous RNA to inhibit breast cancer metastasis
Hu, J., Li, X., Guo, X., Guo, Q., Xiang, C., Zhang, Z., Xing, Y., Xi, T., & Zheng, L. (2017) · Journal of Cell Science · doi:10.1242/jcs.202127 · Cited by 40
Cheng, L., Zheng, L., Yu, X., Tan, Z., Zhang, Y., Xia, M., Wang, Z., & Xi, T. (2017) · FEBS Letters · doi:10.1002/1873-3468.12608 · Cited by 39
ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
Hałoń, A., Donizy, P., Surowiak, P., & Matkowski, R. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0125-9 · Cited by 36
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
Kojima, T., Shimazui, T., Horie, R., Hinotsu, S., Oikawa, T., Kawai, K., Suzuki, H., Meno, K., Akaza, H., & Uchida, K. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20750 · Cited by 35
Song, W., Tang, L., Xu, Y., Sun, Q., Yang, F., & Guan, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0545-x · Cited by 35
The progress of circular RNAs in various tumors.
Wang, D., Yang, S., Wang, H., Wang, J., Zhang, Q., Zhou, S., He, Y., Zhang, H., Deng, F., Xu, H., et al. (2018) · Europe PMC (PubMed Central) · Cited by 35
Zheng, T., Chou, J., Zhang, F., Liu, Y., Ni, H., Li, X., Zheng, L., Tang, T., Jin, L., & Xi, T. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.05.010 · Cited by 33
Chen, J., Xu, J., Li, Y., Zhang, J., Chen, H., Lu, J., Wang, Z., Zhao, X., Xu, K., Li, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14361 · Cited by 33
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study
Galasso, M., Costantino, G., Pasquali, L., Minotti, L., Baldassari, F., Corrà, F., Agnoletto, C., & Volinia, S. (2016) · International Journal of Genomics · doi:10.1155/2016/4503840 · Cited by 31
Kim, M.-H., Kim, H.-B., Acharya, S., Sohn, H. M., Jun, J. Y., Chang, I. Y., & You, H. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01484-08 · Cited by 30
Pseudogene CYP4Z2P 3′UTR promotes angiogenesis in breast cancer
Zheng, L., Li, X., Gu, Y., Ma, Y., & Xi, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.112 · Cited by 27
Zhao, J., Wu, X., Ling, X., Lin, Z., Fu, X., Deng, Y.-H., He, H., & Zhong, W. (2013) · Medical Oncology · doi:10.1007/s12032-013-0465-3 · Cited by 27
Zheng, L., Li, X., Chou, J., Xiang, C., Guo, Q., Zhang, Z., Guo, X., Gao, L., Xing, Y., & Xi, T. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.11.002 · Cited by 27
Circulating hTERT DNA in early breast cancer.
Divella, R., Tommasi, S., Lacalamita, R., Daniele, A., Abbate, I., Garrisi, V. M., Savino, E., Coviello, M., Rubini, V., SIMONE, G. D., et al. (2009) · PubMed · Cited by 26
Britschgi, A., Radimerski, T., & Bentires‐Alj, M. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.10.001 · Cited by 24
SPARC modulates expression of extracellular matrix genes in human trabecular meshwork cells
Wei, H., Liu, J., Lv, B., Lin, X., & Fu, S. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02283.x · Cited by 15
Levy‐Nissenbaum, O., Ehud, B., Tamar, B.-G., Sagi‐Assif, O., Kloog, Y., & Witz, I. P. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.024 · Cited by 13
Molecular basis of breast cancer
Al‐Mansouri, L. J., & Alokail, M. S. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3265 · Cited by 11
Cited by
Prognostic Roles of ceRNA Network-Based Signatures in Gastrointestinal Cancers
Qi, X., Chen, X., Zhao, Y., Chen, J., Niu, B., & Shen, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.921194 · Cited by 22
Metadata
- Authors
- Abdollahzadeh, R., Daraei, A., Mansoori, Y., Sepahvand, M., Amoli, M. M., & Tavakkoly‐Bazzaz, J.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-12-10
- Volume
- 234
- Issue
- 7
- Pages
- 10080-10100
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2904056104
- Cited by
- 261
- References
- 181
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.